Sealed for Safety: A Deep Dive into Container Closure Integrity

News
Webcast

Webcasts

Webinar Date/Time: Wed, Oct 2, 2024 9:00 AM EDT

How pharmaceutical packaging is designed to prevent leakage and contamination, and ensure the quality of injectable drugs.

Register Free: https://www.pharmtech.com/pt_w/sealed-for-safety

Event Overview:

Container closure integrity (CCI) plays a vital role in the packaging of injectable drugs. It is crucial for guaranteeing the safety and effectiveness of these medications, as any compromise in the container's seal can result in microbial contamination or a decrease in drug potency. Join us for an insightful webinar where industry experts will delve into the intricacies of pharmaceutical packaging, uncovering how it is meticulously designed to prevent leakage and contamination, and ensure the utmost quality of injectable drugs.


Key Learning Objectives:

  • Discover the essential factors of CCI and the testing methods utilized to mitigate potential risks
  • Learn how to assess CCI and ensure the utmost quality of injectable drugs
  • Discover the advantages of collaborating with packaging suppliers to create a holistic packaging solution for injectable drug developers


Who Should Attend:

  • Quality/regulatory personnel in parenteral drug delivery
  • Formulation scientists and packaging engineers
  • Device development engineers and managers
  • Technical functions surrounding drug delivery systems
  • Extractable and leachable experts
  • Procurement professionals

Speaker:

Yitian Xiao
Technical and Scientific Expert
Datwyler

Yitian Xiao is currently a Technical and Scientific Expert at Datwyler and brings a breadth of experience to support for Datwyler’s customers on their product development needs. He previously worked in a commercial development role at Becton Dickinson (BD) providing pharmaceutical customers with consultation on BD products, services, and solutions to meet their development timeline needs. Prior to BD, he was a combination product R&D engineer at AstraZeneca responsible for managing technical aspects of device development, such as user needs, test method development, design verification, and design validation. Yitian holds a M.Eng in Biomedical Engineering from Cornell University and a B.S. in Biomedical Engineering from Georgia Tech.

Register Free: https://www.pharmtech.com/pt_w/sealed-for-safety